SCHEMBL19501145

SCHEMBL19501145

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5c6ccccc6c6ccccc6c45)cc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 4/20 0.45
▸ MAPT P10636 3/20 0.45
▸ ATM Q13315 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ ADORA3 P0DMS8 2/20 0.42
▸ ADORA2A P29274 2/20 0.42
▸ ADORA2B P29275 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20760762 0.90 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL19501141 0.90 TSHR (0.47) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL19172218 0.90 TSHR (0.47) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL16787504 0.90 MEN1 (0.54) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL21636501 0.90 ENPP1 (0.44) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL19501146 0.90 MEN1 (0.42) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL19501142 0.89 ALDH1A1 (0.42) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL16158728 0.88 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL8053087 0.88 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL27456218 0.88 L3MBTL1 (0.52) L3MBTL1MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013426-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2021-01-14 — — US disclosed
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-10-26 — — US disclosed
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013426-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 L3MBTL1 4661/4885MEN1 2720/4885KMT2A 4687/4885
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 L3MBTL1 4661/4885MEN1 2720/4885KMT2A 4687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback